Chronic Myeloid Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
Medco announces new offerings within Advanced Oncology Solutions

Medco announces new offerings within Advanced Oncology Solutions

Indirubin might help treat glioblastoma

Indirubin might help treat glioblastoma

Common cell pathway could lead to new treatments for autoimmune diseases and cancer

Common cell pathway could lead to new treatments for autoimmune diseases and cancer

Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

Placental growth factor also plays a role in chronic myeloid leukemia

Placental growth factor also plays a role in chronic myeloid leukemia

QIAGEN to acquire Ipsogen

QIAGEN to acquire Ipsogen

Researchers investigate the role of PlGF in mice with chronic myeloid leukemia

Researchers investigate the role of PlGF in mice with chronic myeloid leukemia

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

LLS announces four new Academic Concierge partnerships for cancer drug development

LLS announces four new Academic Concierge partnerships for cancer drug development

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

Customizing targeted therapies to each tumor's molecular characteristics may effectively treat cancer

Customizing targeted therapies to each tumor's molecular characteristics may effectively treat cancer

ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011

ARIAD's ponatinib initial Phase 1 study data on acute myeloid leukemia to be presented at ASCO 2011

Leukemia protein plays a role in Alzheimer's disease

Leukemia protein plays a role in Alzheimer's disease

New combination therapy eradicates acute lymphoblastic leukemia in children, older adults

New combination therapy eradicates acute lymphoblastic leukemia in children, older adults

Bristol-Myers Squibb to present abstracts on oncology compounds at ASCO 2011 Annual Meeting

Bristol-Myers Squibb to present abstracts on oncology compounds at ASCO 2011 Annual Meeting

New study sheds light on origins of myeloid leukemia

New study sheds light on origins of myeloid leukemia

Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

CytRx reports $6.3 million net loss for first quarter 2011

CytRx reports $6.3 million net loss for first quarter 2011

Clontech releases iDimerize inducible dimerization systems

Clontech releases iDimerize inducible dimerization systems

Novel drug holds potential against resistant chronic myeloid leukemia

Novel drug holds potential against resistant chronic myeloid leukemia